Prognosis of Lymph Node Failure Patients after Treatment for Early Stage Extranodal Nasal-Type NK/T-cell Lymphoma

陈波,李晔雄,刘清峰,金晶,王维虎,王淑莲,刘跃平,宋永文,房辉
DOI: https://doi.org/10.3760/cma.j.issn.1009-9921.2014.05.002
2014-01-01
Abstract:Objective To evaluate the survival and prognostic factors of patients with lymph node failure after treatment for early stage upper aerodigestive tract NK/T-cell lymphoma (UADT-NKTCL).Methods Between April 1988 and December 2012,40 patients with Ⅰ and Ⅱ UADT-NKTCL who developed lymphatic failure after treatment were reviewed.Survivals were estimated using the Kaplan-Meier method.Results Of 40 patients,8 patients developed regional lymphatic failure,26 patients developed distant lymphatic failure,and 6 patients had both regional and distant lymphatic failure.57.1% (8/14) patients with regional lymphatic failure also had local relapse,and 71.9 % (23/32) patients with distant lymphatic failure had distant extranodal failure.The 2-year overall survival (OS) rate after lymphatic failure was 29.8 %,with a median survival of 8.7 months.B symptoms and ECOG status after lymphatic failure were prognostic factors.The median survivals of patients with or without B symptoms were 6.6 months and 16.3 months (P =0.034),respectively.The patients with good status (ECOG score =0-1) after lymphatic failure had better median smvivals than those with poor status (ECOG score ≥2) (31.6 months vs 4.1 months,P < 0.001).In addition,patients who received salvage combined modality therapy had better OS than received salvage chemotherapy alone,with the 2-year OS rates of 68.6 % and 15.0 % (P < 0.001),respectively.Conclusions Early stage UADT-NKTCL patients with lymphatic failure has poor prognosis.Salvage combined-modality therapy could achieve better outcome.
What problem does this paper attempt to address?